NUBLOXANT Trademark

Trademark Overview


On Friday, August 6, 2010, a trademark application was filed for NUBLOXANT with the United States Patent and Trademark Office. The USPTO has given the NUBLOXANT trademark a serial number of 85102043. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Tuesday, August 16, 2011. This trademark is owned by Novartis AG. The NUBLOXANT trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; Antibiotic preparations; Antifungal preparations; Antivirals; Diagnostic preparations for medical and veterinary use; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment and prevention of disorders of the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders and metabolic diseases, for use in dermatology, in oncology, in hematology, in transplantation, in ophthalmology and for use in the gastroenterological area; Vaccines
nubloxant

General Information


Serial Number85102043
Word MarkNUBLOXANT
Filing DateFriday, August 6, 2010
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateTuesday, August 16, 2011
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 18, 2011

Trademark Statements


Goods and ServicesAnti-infectives; Antibiotic preparations; Antifungal preparations; Antivirals; Diagnostic preparations for medical and veterinary use; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment and prevention of disorders of the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders and metabolic diseases, for use in dermatology, in oncology, in hematology, in transplantation, in ophthalmology and for use in the gastroenterological area; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateTuesday, August 16, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events


Event DateEvent Description
Tuesday, August 16, 2011ABANDONMENT NOTICE MAILED - AFTER PUBLICATION
Tuesday, August 16, 2011ABANDONMENT - AFTER PUBLICATION
Monday, August 15, 2011TEAS EXPRESS ABANDONMENT RECEIVED
Tuesday, March 15, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 18, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 18, 2011PUBLISHED FOR OPPOSITION
Wednesday, December 15, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, December 15, 2010ASSIGNED TO LIE
Monday, November 22, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 22, 2010ASSIGNED TO EXAMINER
Wednesday, August 11, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, August 10, 2010NEW APPLICATION ENTERED IN TRAM